Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Carboxylic acids and derivatives
(total 11 related compounds in database, current show from 1 to 10)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
2-(5-(4-(Benzyloxy)benzylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid Depiction based on curated SMILES HO O S S N O O Staphylococcus α-hemolysin Preclinical (in vivo) Gao P, et al. 2018. Proc Natl Acad Sci U S A
5beta,6alpha-Bis[4-[(4,5-dibromo-1H-pyrrole-2-yl)carbonylaminomethyl]-1H-1,2,3-triazole-1-ylmethyl]-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine Depiction based on curated SMILES N H N NH O N Br Br N H N N N H N H N NH 2 N H O Br Br HN Acinetobacter
Staphylococcus		 Biofilm
Biofilm		 Preclinical (in vitro)
Preclinical (in vitro)		 Huigens RW 3rd, et al. 2009. Org Biomol Chem
[(2R)-6-azaniumyl-1-[3-[3-[[(2R)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-hexadecanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES + N H H H N H O H H + N H H H + N H H H CH 3 O N N H O H + N H H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2R)-6-azaniumyl-1-[3-[3-[[(2R)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-tetradecanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES + N H H H HN O H + N H H H + N H H H O H 3 C N HN O H + N H H H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-decanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES H + N H H H N H O + N H H H + N H H H O N CH 3 N H O H + N H H H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-dodecanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES H + N H H H N H O + N H H H + N H H H O N CH 3 N H O H + N H H H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-hexadecanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES + N H H H N H O H H + N H H H + N H H H CH 3 O N N H O H + N H H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-octadecanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES O + N H H H + N H H H N H H + N H H H + N H H H CH 3 O N N H O H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-tetradecanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES + N H H H HN O H + N H H H + N H H H O H 3 C N HN O H + N H H H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-[(9E,12E)-octadeca-9,12-dienoyl]amino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES O + N H H H + N H H H N H H + N H H H + N H H H CH 3 O N N H O H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page  1  2 



Back to top
2004-2024 NIPB, CAMS&PUMC